Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Finasteride effectively treats baldness but may cause sexual side effects.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Doctors need to be better prepared to assess and treat obesity in patients.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

SHBG may be a useful early indicator and treatment target for PCOS.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.